Akeso, Inc. (HKG:9926)
Hong Kong · Delayed Price · Currency is HKD 135.50
+7.80 (6.11%)
Sep 12, 2025, 4:08 PM HKT
Akeso Market Cap
Akeso has a market cap or net worth of 124.81 billion as of September 12, 2025. Its market cap has increased by 212.69% in one year.
Market Cap
124.81B
Enterprise Value
121.88B
Revenue
2.75B
Ranking
n/a
PE Ratio
n/a
Stock Price
135.50
Market Cap Chart
Since April 24, 2020, Akeso's market cap has increased from 18.54B to 124.81B, an increase of 573.07%. That is a compound annual growth rate of 42.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 124.81B | 129.09% |
| Dec 31, 2024 | 54.48B | 39.61% |
| Dec 29, 2023 | 39.03B | 7.91% |
| Dec 30, 2022 | 36.17B | 30.19% |
| Dec 31, 2021 | 27.78B | -7.12% |
| Dec 31, 2020 | 29.91B | 61.28% |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 269.07B |
| JD Health International | 220.26B |
| Hansoh Pharmaceutical Group Company | 213.09B |
| Innovent Biologics | 166.31B |
| Sino Biopharmaceutical | 150.95B |
| WuXi Biologics | 146.30B |
| Alibaba Health Information Technology | 116.02B |
| CSPC Pharmaceutical Group | 115.70B |